uniQure N.V. (NASDAQ: QURE)
$9.13
+0.4100 ( +4.70% ) 4.0M
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
Market Data
Open
$9.13
Previous close
$8.72
Volume
4.0M
Market cap
$442.29M
Day range
$8.54 - $9.75
52 week range
$3.73 - $11.35
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 09, 2024 |
8-k | 8K-related | 15 | Jul 01, 2024 |
4 | Insider transactions | 1 | Jun 28, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |
4 | Insider transactions | 1 | Jun 21, 2024 |